Screen every supplier against OFAC SDN, EU restrictive measures, UN sanctions, and FDA Import Alert detention lists in one query.
The sanctions catalog indexes 66 active listings across OFAC SDN, EU restrictive measures, and FDA Import Alert 66-40 detention orders. The screen is mandatory pre-contract: any supplier on an active sanctions or DWPE list should be blocked or require C-suite exception. PharmaDB resolves each supplier to its corporate parent, then matches against the sanctions registry weekly. The screen surfaces below as a feed of recent listings and changes.
Upload or define your supplier base. PharmaDB resolves each to its corporate parent and plant entities.
Every active sanctions and DWPE listing is matched against the resolved list weekly. Hits surface with the listing date, the cited mechanism, and the corporate scope.
Citation-anchored sanctions list with the exception register entry per hit. Useful for the legal team's pre-contract screen and the C-suite exception review.
OFAC SDN, EU restrictive measures, UN sanctions, and FDA Import Alert DWPE lists in one screen. Three sanctions regimes plus the FDA's border-level mechanism.
A sanction against a subsidiary blocks the corporate parent unless explicitly carved out. The screen resolves each supplier to its corporate parent so subsidiary risk surfaces in the parent's view.
New listings appear within days of publication; delistings flip the chip to inactive on the next refresh. The screen is live, not snapshot-based.
C-suite exceptions documented per hit. Useful for legal-team audit trail and procurement defensibility.
A real chat thread in PharmaDB. Type a question, the AI agent runs the tools, the answer lands as a saveable note.
pharmagraph_query Twelve plants currently under FDA Import Alert 66-40 detention · the dominant DWPE jurisdiction is India · live warehouse.
The sanctions screen is the mandatory pre-contract gate. PharmaDB joins OFAC SDN, EU restrictive measures, UN sanctions, and FDA Import Alert DWPE listings against the supplier base at the corporate-parent level. The view is company_sanctions plus compliance_events filtered to import-alert events. Refresh cadence is weekly.
OFAC SDN (US Treasury), EU restrictive measures (Council Regulation), UN sanctions (Security Council), and FDA Import Alert detention orders (66-40, 66-41, other). The catalog includes the corporate-parent resolution so a subsidiary hit surfaces under the parent's view.
DWPE is operationally equivalent to a sanction at the US border. Products are detained without physical examination; the contract effect is the same as a sanctions block for any supplier exporting into the US. Procurement and legal teams treat the listings together.
Each supplier is resolved to its corporate-parent entity via the legal-entities table. A sanction against a subsidiary surfaces in the parent's screen unless explicit carve-outs apply. The catalog row carries both the cited entity and the resolved parent.
Sanctions lists refresh weekly. OFAC SDN publishes near-real-time; the catalog pulls each refresh and surfaces new listings within days. FDA Import Alerts publish weekly. Each row carries the listing date and the delisting date once removed.
Denied-party lists (BIS Entity List, OFAC FSE, EU Dual-Use) are tracked in the same screening view. The catalog includes the underlying mechanism so the legal team can match the right contract clause to the hit.
Yes. The screen is intended as the mandatory pre-contract gate. Any supplier with an active hit should require C-suite exception or be blocked. The exception register is the audit-trail surface for documented exceptions.
Bring the molecule, the lane, or the supplier you're sourcing this week. The AI agent runs it on PharmaDB in 30 minutes. You keep the brief.